NEOSTIGMINE METHYLSULFATE INJECTION USP 1 MG
NEOSTIGMINE METHYLSULFATE : 1 MG · DIN 02475499 · MARCAN PHARMACEUTICALS INC
Health Canada status: MARKETED
What is NEOSTIGMINE METHYLSULFATE INJECTION USP?
NEOSTIGMINE METHYLSULFATE INJECTION USP 1 MG contains NEOSTIGMINE METHYLSULFATE : 1 MG. It is listed in the Health Canada Drug Product Database under DIN 02475499, held by MARCAN PHARMACEUTICALS INC, supplied as SOLUTION for INTRAVENOUS ; SUBCUTANEOUS ; INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 26-Mar-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02475499 |
|---|---|
| Brand name | NEOSTIGMINE METHYLSULFATE INJECTION USP |
| Generic / active ingredient | NEOSTIGMINE METHYLSULFATE : 1 MG |
| Manufacturer | MARCAN PHARMACEUTICALS INC |
| Strength | 1 MG |
| Dosage form | SOLUTION |
| Route of administration | INTRAVENOUS ; SUBCUTANEOUS ; INTRAMUSCULAR |
| Schedule | Prescription |
| ATC code | N07AA01 NEOSTIGMINE |
| AHFS class | 12:04.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 26-Mar-2019 |
| Original market date | 2019-03-26 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code N07AA01 NEOSTIGMINE. 6 of 26 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| NEOSTIGMINE METHYLSULFATE INJECTION USP | 0.5 MG | SOLUTION | MARCAN PHARMACEUTICALS INC | MARKETED | DIN 02475480 |
| NEOSTIGMINE METHYLSULFATE INJECTION, USP | 0.5 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED | DIN 02537516 |
| NEOSTIGMINE OMEGA | 0.5 MG | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02230593 |
| NEOSTIGMINE OMEGA | 1 MG | LIQUID | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02230592 |
| NEOSTIGMINE OMEGA | 2.5 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02387166 |
| NEOSTIGMINE METHYLSULFATE INJ 0.5MG/ML USP | .5 MG | LIQUID | DAVID BULL LABORATORIES (PTY) LTD. | CANCELLED POST MARKET | DIN 01904183 |
| NEOSTIGMINE METHYLSULFATE INJ 1MG/ML USP | 1 MG | LIQUID | DAVID BULL LABORATORIES (PTY) LTD. | CANCELLED POST MARKET | DIN 01914588 |
| NEOSTIGMINE METHYLSULFATE INJECTION | 0.5 MG | LIQUID | FRESENIUS KABI CANADA LTD | CANCELLED PRE MARKET | DIN 02243104 |
| NEOSTIGMINE METHYLSULFATE INJECTION | 1 MG | LIQUID | FRESENIUS KABI CANADA LTD | CANCELLED PRE MARKET | DIN 02243103 |
| NEOSTIGMINE METHYLSULFATE INJECTION SDZ | 0.5 MG | SOLUTION | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | DIN 02385201 |
Who else supplies NEOSTIGMINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. NEOSTIGMINE appears in 12 registered pack listings across 4 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.